Medicaid is probably the most innovative program in healthcare today. Its flexibility, adaptability, and focus on whole-person care have made it a leader in addressing the complex needs of vulnerable populations, and it offers useful examples of how to embrace true risk-based, value-based reimbursement. The post If We Want a More Innovative Healthcare System, Look…
It is time we realize that there is no single panacea for mental health; the need to break down barriers for working families and individuals in rural towns or underserved communities requires we move past a narrow definition of telehealth. The post The Miscalculation of Teletherapy: Why Digital Mental Health Goes Beyond Virtual Sessions appeared…
Ask any healthcare revenue cycle manager how they feel about using artificial intelligence (AI), and the response is likely to be “hopeful, but wary.” The potential is clear — fewer denials, faster reimbursements and more efficient workflows. However, with adoption slowing, it seems many have lingering concerns about implementation. According to Experian Health’s State of…
Few voters likely expected President Donald Trump in the first weeks of his administration to slash billions of dollars from the nation’s premier federal cancer research agency. But funding cuts to the National Institutes of Health were presaged in Project 2025’s “Mandate for Leadership,” a conservative plan for governing that Trump said he knew nothing…
Republicans in Congress have suggested big cuts to Medicaid. But what exactly is it? Medicaid, the state-federal health insurance program for people with low incomes or disabilities, is integral to the U.S. health care system. It keeps hospitals and other providers afloat, provides a key source of federal funds to states, and helps provide health…
HELENA, Mont. — Despite concerns about what Congress and the Trump administration might have planned for Medicaid, Montana’s Republican-led legislature and GOP governor appear ready to keep the state’s Medicaid expansion program in place beyond its scheduled end date this summer. State lawmakers don’t have the luxury of waiting until the federal picture sharpens. They…
Healthcare AI is developing at a rapid rate, and the industry’s attitude on how to best regulate and deploy this technology is evolving every day, according to leaders attending this year’s ViVE conference. The post ‘The Hardest Thing Is Separating the Wheat from the Chaff’: 5 Leaders on the State of Healthcare AI appeared first…
Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others believe these drugs are dangerous for patients. The post Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe? appeared first on MedCity News.
BridgeBio Pharma’s approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more. The post On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval appeared first on MedCity…
The distinction between value-based care and value-based payment isn’t merely semantic — it represents a crucial fork in the road for healthcare delivery. As AI and other technologies become more prevalent in healthcare, we must ensure they’re deployed in service of improving patient care rather than merely optimizing revenue. The post The Dark Side of…